Login / Signup

Considerations for SGLT2 inhibitor use in post-transplantation diabetes.

Manfred HeckingTrond Jenssen
Published in: Nature reviews. Nephrology (2020)
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • cell therapy
  • adipose tissue
  • mesenchymal stem cells